Clonmel Healthcare wins patent rights to cholesterol drug

An Irish pharmaceutical manufacturer has succeeded in a High Court counterclaim against international giant Merck Sharp and Dohme (MSD) in a patent rights row over a cholesterol reducing drug.

MSD had sued Clonmel Healthcare claiming the defendant was breaching its 2005 supplementary protection certificate (SPC), governing MSD's authorisation for its drug "Inegy".